Seizures in children undergoing stem cell transplantation

Eulalia Turón-Viñas1,2, Iván López-Torija3, Elisabet Coca-Fernández1,2

  • 1Child Neurology Unit, Pediatrics Service, Hospital Sant Pau, Barcelona, Spain.

PubMed

Insights

Neurological complications, particularly seizures, are a significant concern after hematological stem cell transplantation (HSCT). Identifying risk factors and early interventions for seizures is crucial for improving patient outcomes and survival rates.

Area of Science:

  • Hematology
  • Neurology
  • Pediatrics

Background:

  • Neurological complications (NCs) are a major concern following hematological stem cell transplantation (HSCT).
  • Seizures are a common presentation of NCs in patients undergoing HSCT.

Purpose of the Study:

  • To analyze the incidence and etiologies of seizures in children undergoing HSCT.
  • To identify risk factors and outcomes associated with seizures post-HSCT.

Main Methods:

  • Retrospective study of 155 children undergoing HSCT between 2002 and 2018.
  • Analysis of seizure incidence, causes, associated factors, and outcomes.

Main Results:

  • 17.4% of children developed seizures within 2 years post-HSCT.
  • Common etiologies included CNS infection, drug toxicity, and vascular disease.
  • Seizures were associated with HSCT type, specific medications, and GVHD, and predicted adverse outcomes including mortality and sequelae.

Conclusions:

  • Neurological complications, especially seizures, significantly impact survival and outcomes in HSCT patients.
  • Addressing neurological complications is essential for improving HSCT procedures and patient management.
Abstract